Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Population of Adult Obese Patients
NCT ID: NCT03394469
Last Updated: 2019-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
800 participants
INTERVENTIONAL
2018-06-04
2020-06-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Cohort of Adult Obese Patients and Longitudinal Follow-up
NCT06880432
Evaluation of Physical Performance in Old Adults With Sarcopenic Obesity
NCT06299241
The Predictive Capacity of Peripheral Muscle Function on Quality of Life Impairment at 1 Year in Subjects With Obesity
NCT05479396
Sarcopenic Obesity as a Risk of Premature Aging
NCT05443711
Sarcopenic Obesity in the Elderly
NCT06083909
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Biological collection to identify plasma, serum, genetic, urinary and faecal biomarkers associated with sarcopenic obesity
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cohort
Collection of clinical and paraclinical data (biological and anthropometric) for evaluation of sarcopenic obesity in obese patients.
collection
Blood, urinary and faecal samples
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
collection
Blood, urinary and faecal samples
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sex: men and women
* Patient followed in clinical nutrition benefiting from a metabolic assessment for optimization of clinical and paraclinical management
* Patient meeting the criteria of obesity defined by BMI\> 30 kg / m²
* Major patient with free, informed and signed consent
* Patient covered by the social security scheme
Exclusion Criteria
* Patient with neuromuscular disease
* Patient with a total inability to walk
* Minor patient
* Refusal of the patient to participate in the study
* Pregnant or lactating women
* Patient deprived of liberty or under guardianship.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yves BOIRIE
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Clermont-Ferrand
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A01510-53.
Identifier Type: OTHER
Identifier Source: secondary_id
CHU-366
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.